(c) 2014  ATHENA ADVISORS LLC  All Rights Reserved


In February 2014 Lisa Troe joined the Board of Directors of The Rubicon Project, Inc. and serves as Chair of the Audit Committee and as a member of the Nominating and Governance Committee.  The Rubicon Project, Inc., which completed its IPO in April, 2014, is a leading technology company automating the buying and selling of advertising.  Lisa also serves on the Boards of Directors of three private companies and is actively seeking board seats on additional public companies.  Lisa brings strong accounting/financial expertise with an extensive background in public company governance and oversight, enterprise risk management, financial investigations and securities litigation. She has worked with boards, committees of boards, executives, and their counsel in complex, crisis driven, mission critical situations to address high level strategic issues that affect the enterprise, C-suite executives, shareholders and other stakeholders. She qualifies as an ÔÇťaudit committee financial expert".  She is a CPA and a member of the American Institute of Certified Public Accountants.  She is a credentialed NACD Governance Fellow and a member of the National Association of Corporate Directors.  See Lisa's short form Director Bio or her long form Director Profile.  Lisa's Director Profile - Oil & Gas includes additional industry specific information.

Chuck Troe presently serves on the Boards of Directors of three private companies and is a director designate of a development stage biotechnology (protein drug discovery technology) company.  He has served on the boards of numerous private companies in diverse businesses, including medical devices, biotechnology, high temperature materials, flat panel display technology, financial services, mining, and oil and gas exploration and production.  For many years he served on the boards of the Life Science Industry Council and the Southern California  Biomedical Council (not for profit corporations).  He served for six years as a director of the Los Angeles Biomedical Research Institute, including five years as chair of the Audit Committee.  As Audit Committee Chair of LA Biomed, he wrote the Audit Committee Charter and he organized and supervised an investigation of senior officer misconduct in contract administration that resulted in presentation of a formal report to the Board of Directors and dismissal of the officer.

Board of Directors Service